Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report.

Longitudinal Evaluation of Polyneuropathy in Atypical Parkinsonian Syndromes.

Corneal confocal microscopy as a paraclinical test in neurodegenerative disease: a scoping review.

DISTRICTS trial: enhancing carpal tunnel syndrome treatment - Authors' reply.

Pearls & Oy-sters: Hereditary Spastic Paraplegia Type 15 Presenting as Juvenile Onset Levodopa-Responsive Parkinsonism.

Electrophysiological and biochemical evaluations of neuropathy risk in oral levodopa versus levodopa/carbidopa intestinal gel treatment.

Phenotypic spectrum of variants in the FIG4 gene: variants associated with Charcot-Marie-Tooth 4J and parkinsonism.

Idiopathic polyneuropathy with neurogenic autonomic failure - an early manifestation of Lewy body disease? a case report.

Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors.

Ocular Surface Changes Associated with Neurological Diseases.

Clinical Reasoning: A 58-Year-Old Man With Resting Tremor, Bradykinesia, and Distal Numbness.

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Clinical and functional analysis of KIF5A related spastic paraplegia type 10.

Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia.

Comorbid pathologies and their impact on progressive supranuclear palsy: current view.

Further delineation of LRSAM1-related Charcot-Marie-Tooth type 2P with parkinsonism.

HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.

Subacute Painful Axonal Polyneuropathy Associated with Foslevodopa/Foscarbidopa Subcutaneous Infusion in Advanced Parkinson's Disease.

Anti-VGLUT2 autoantibodies in neurological diseases.

High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic.

Identification of GGC Repeat Expansions in ZFHX3 among Chilean Movement Disorder Patients.

Objective assessments for walking aid prescription in balance impairment and falls risk: a scoping review of current evidence.

Phenotypic and molecular characterization of a recurrent SPTAN1 mutation causing SPG91.

Motor Neuron Involvement in Two ATP13A2-Related Families: ALS And HSP-Like Phenotypes.

Three Cases of Spinocerebellar Ataxia Type 2 (SCA2) and Pediatric Literature Review: Do Not Forget Trinucleotide Repeat Disorders in Childhood-Onset Progressive Ataxia.

Effect of Brief Electrical Stimulation on Cell Biomechanics in Hereditary Sensory Neuropathy.

Neurotoxicity of levodopa/carbidopa intestinal gel preparations can cause polyneuropathy in Parkinson's Disease patients.

Heterozygous variants in AP4S1 are not associated with a neurological phenotype.

[Neurology: what's new in 2024].

Blended phenotype of TECPR2-associated hereditary sensory-autonomic neuropathy and Temple syndrome.

A Novel GBF1 Variant in a Charcot-Marie-Tooth Type 2: Insights from Familial Analysis.

Expanding molecular and clinical spectrum of CPT1C-associated hereditary spastic paraplegia (SPG73)-a case series.

Polyneuropathy in Parkinson's Disease is Highly Prevalent and Not Related to Treatment.

Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data.

Comparison of Clinical and Electrophysiologic Characteristics of Peripheral Neuropathy in Progressive Supranuclear Palsy and Parkinson's Disease: An Observational Study.

Polyneuropathy and levodopa therapy in Parkinson's Disease: an evolving clinical challenge.

Unraveling Isoform Complexity: The Roles of M1- and M87-Spastin in Spastic Paraplegia 4 (SPG4).

Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson's Disease.

A Homoplasmic MT-TV Mutation Associated with Mitochondrial Inheritance of Hereditary Spastic Paraplegia.

Large-fiber neuropathy in Parkinson's disease: a narrative review.

FIG4-Related Parkinsonism and the Particularities of the I41T Mutation: A Review of the Literature.

Assessment of swallowing performance in patients with neurodegenerative disease: A hierarchical cluster analysis.

Robot-assisted gait training in patients with various neurological diseases: A mixed methods feasibility study.

Neurofilaments in neurologic disease.

Longitudinal evaluation of polyneuropathy in Parkinson's disease.

[Influence of neurological diseases on mobility and ability to drive].

MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study.

Parkinson's disease and vitamins: a focus on vitamin B12.

Association between cytomegalovirus infection and neurological disorders: A systematic review.

RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity.

Clinical and Genetic Spectrum in a Large Cohort of Hereditary Spastic Paraplegia.

A novel ATP13A2 variant causing complicated hereditary spastic paraplegia.

Fragile X premutation mimicking late onset hereditary spastic paraplegia.

Expert commentary for fragile X premutation mimicking late onset hereditary spastic paraplegia.

Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations.

Movement disorders in hereditary spastic paraplegias.

Biallelic COQ4 Variants in Hereditary Spastic Paraplegia: Clinical and Molecular Characterization.

Rare variant analysis of UQCRC1 in Chinese patients with early-onset Parkinson's disease.

A novel frameshift DDHD1 mutation in a patient with hereditary spastic paraplegia type 28: Case report and review of the literature.

Clinical and genetic features of patients suffering from CMT4J.

Guillain-Barré syndrome following subthalamic nucleus - Deep Brain Stimulation in Parkinson's disease: A case report.

Impact of social-functioning and sleep on quality of life in chronic inflammatory demyelinating polyneuropathy.

The comorbidity and co-medication profile of patients with progressive supranuclear palsy.

Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrum.

Examining the National Representativeness of the Axon Registry: A Neurology-Specific Patient Registry.

Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4-Related Hereditary Spastic Paraplegia.

Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out.

Alu Retrotransposition Event in SPAST Gene as a Novel Cause of Hereditary Spastic Paraplegia.

Epidemiology of small intestinal bacterial overgrowth.

Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.

Parkinsonism in spinocerebellar ataxia with axonal neuropathy caused by adult-onset COA7 variants: a case report.

A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson's disease.

Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series.

Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS cohort.

The value of electrochemical skin conductance measurement by Sudoscan® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes.

Prevalence and Risk Factors of Peripheral Neuropathy in Parkinson's Disease.

Early-onset parkinsonism and hereditary spastic paraplegia type 7: pearls and pitfalls.

Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson's disease.

Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report.

UQCRC1 variants in early-onset and familial Parkinson's disease in a Taiwanese cohort.

Multiple neurological effects associated with exposure to organophosphorus pesticides in man.

Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis.

Autophagic lysosome reformation in health and disease.

The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15.

Novel RAB39B mutation (c.309G > A)-related spastic paraparasis: case report.

Investigating KIF1A mutations in a Taiwanese cohort with hereditary spastic paraplegia.

Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

Specific Gait Changes in Prodromal Hereditary Spastic Paraplegia Type 4: preSPG4 Study.

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

The 2022 Lady Estelle Wolfson lectureship on neurofilaments.

Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report.

Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients.

SPG11 presenting with dystonic tremor in childhood.

Clinical and Genetic Aspects of Childhood-Onset Demyelinating Charcot-Marie-Tooth's Disease in Brazil.

Genetic, structural and clinical analysis of spastic paraplegia 4.

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.

Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network.

Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation.

Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases.

New spinocerebellar ataxia subtype caused by SAMD9L mutation triggering mitochondrial dysregulation (SCA49).

Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings.

Increased trunk movements in people with hereditary spastic paraplegia: do these involve balance correcting strategies?

DNAJB2-related Charcot-Marie-Tooth disease type 2: Pathomechanism insights and phenotypic spectrum widening.

Neurological symptoms and disorders following electrical injury: A register-based matched cohort study.

Assessing the NOTCH2NLC GGC repeat expansion in Taiwanese patients with hereditary spastic paraplegia.

De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study.

A Clinical and Integrated Genetic Study of Isolated and Combined Dystonia in Taiwan.

The second family affected with a PRDM8-related disease.

Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination.

NAD+ Metabolism and Diseases with Motor Dysfunction.

Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.

Direct and Indirect Neurological Signs of COVID-19.

History of Ataxias and Paraplegias with an Annotation on the First Description of Striatonigral Degeneration.

Socio-Economic Disparities in Access to Diagnostic Neuroimaging Services in the United Kingdom: A Systematic Review.

Orthostatic myoclonus - A retrospective study of Asian patients.

Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.

Early Onset Degenerative Parkinsonism - Consider SPG7 Mutation.

Anticipation in Genetic Diseases: Moving Beyond Nucleotide Repeat Disorders.

Clinical Reasoning: A Middle-aged Man With Progressive Gait Abnormalities.

Identifying the Effects of Reactive Oxygen Species on Mitochondrial Dynamics and Cytoskeleton Stability in Dictyostelium discoideum.

The m.3890G>A/MT-ND1 mtDNA rare pathogenic variant: Expanding clinical and MRI phenotypes.

The Impact of the COVID-19 Lockdown on the Quality of Life in Chronic Neurological Diseases: The Results of a COVQoL-CND Study.

C19orf12 mutation causing mitochondrial membrane-protein Associated Neurodegeneration masquerading as spastic paraplegia.

Higher incidence of cervical spinal cord compression in amyotrophic lateral sclerosis: a single-institute cohort study.

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.

Transactivation response DNA-binding protein of 43 kDa proteinopathy and lysosomal abnormalities in spastic paraplegia type 11.

Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan.

Fludrocortisone for orthostatic hypotension.

Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11?

The case of a 51-year-old man with 15 years of progressive leg spasticity.

A novel homozygous mutation in ATP13A2 gene causing pure hereditary spastic paraplegia.

Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia.

GCH1 mutations in hereditary spastic paraplegia.

Paroxysmal, exercise-induced, diurnally fluctuating dystonia: Expanding the phenotype of SPG8.

Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7.

Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.

Brain Damage and Gene Expression Across Hereditary Spastic Paraplegia Subtypes.

A follow-up study on restless legs syndrome in chronic obstructive pulmonary disease population.

Expanding the Spectrum of AP5Z1-Related Hereditary Spastic Paraplegia (HSP-SPG48): A Multicenter Study on a Rare Disease.

Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods.

Viral infections and their relationship to neurological disorders.

Acute motor axonal polyneuropathy in one parkinsonian patient receiving moderate dosage of oral levodopa.

Improving gait adaptability in patients with hereditary spastic paraplegia (Move-HSP): study protocol for a randomized controlled trial.

Spinal cord stimulation improves motor function and gait in spastic paraplegia type 4 (SPG4): Clinical and neurophysiological evaluation.

[Direct and indirect neurological manifestations of COVID-19].

Mitochondria and Parkinson's disease: a complex (III) liaison.

Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature.

SPG46 due to truncating mutations in GBA2: Two cases from India.

RNF170-Related Hereditary Spastic Paraplegia: Confirmation by a Novel Mutation.

''Eye of tiger sign" mimic in patients with spastic paraplegia gene 7 (SPG7) mutations.

Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy.

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics.

Charcot-Marie-Tooth disease type 4J with spastic quadriplegia, epilepsy and global developmental delay: a tale of three siblings.

Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene.

Update on Neurological Manifestations of SARS-CoV-2.

Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia.

Sensory Neuropathy in Parkinson Disease: Electrodiagnostic Evaluation.

[Neurological complications of hepatitis C infections].

A hereditary spastic paraplegia predominant phenotype caused by variants in the NEFL gene.

Homozygosity mapping and next generation sequencing for the genetic diagnosis of hereditary ataxia and spastic paraplegia in consanguineous families.

Clarification of undiagnosed ataxia using whole-exome sequencing with clinical implications.

Correlates of polyneuropathy in Parkinson's disease.

Identification of UBAP1 mutations in juvenile hereditary spastic paraplegia in the 100,000 Genomes Project.

Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation.

Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.

Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations.

Neurological letter from Bangladesh.

RTN2-gene associated spastic paraplegia in an indian patient with anterior horn cell involvement.

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients.

Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.

Lentiform fork sign in a patient with systemic lupus erythematosus.

COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia.

Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia.

Bi-allelic variants in PNPLA6 possibly associated with Parkinsonian features in addition to spastic paraplegia phenotype.

Maximizing placebo response in neurological clinical practice.

Tumors masquerading as neurological diseases: A caution for clinicians in planning diagnosis and treatment.

Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.

Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson's disease: results of the Italian GLORIA patient population.

Small heat shock proteins in neurodegenerative diseases.

Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training.

The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy.

FIG4 mutations leading to parkinsonism and a phenotypical continuum between CMT4J and Yunis Varón syndrome.

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.

Association Between Neurological Disorders and Death by Suicide in Denmark.

Mutation analysis of CAPN1 in Chinese populations with spastic paraplegia and related neurodegenerative diseases.

Small fiber neuropathy in unexpected clinical settings: a review.

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease.

Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion.

An overview of pain in Parkinson's disease.

Chronic neurological disorders and related comorbidities: Role of age-associated physiological changes.

Novel mutations in the SPAST gene cause hereditary spastic paraplegia.